Beyond MariTide, Amgen has a rich pipeline with more than 30 phase 3 programs. Some are for existing medicines seeking label expansions, such as Lumakras and Amjevita, a rheumatoid arthritis medicine.

A cheap antidepressant drug may be able to treat a particularly aggressive, currently incurable brain tumour, Swiss ...

Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug ...

The Food and Drug Administration issued a rule in March 2023 that requires health care professionals to notify people if they have dense breasts. Studies have shown dense breast tissue can make it ...

Researchers have now found a substance that effectively combats glioblastomas, at least in the laboratory: an antidepressant ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

Scientists have discovered hundreds of genes that could potentially promote cancer, new research shows. Cancer is typically ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

Vortioxetine, an antidepressant, shows promise against glioblastoma in lab tests conducted by ETH Zurich, leading to forthcoming clinical trials. Glioblastoma is an incurable and fatal type of brain ...